share_log

Positive Earnings Growth Hasn't Been Enough to Get PKU HealthCareLtd (SZSE:000788) Shareholders a Favorable Return Over the Last Five Years

Positive Earnings Growth Hasn't Been Enough to Get PKU HealthCareLtd (SZSE:000788) Shareholders a Favorable Return Over the Last Five Years

在过去五年中,正收益增长不足以让北京大学医疗保健有限公司(深圳证券交易所代码:000788)股东获得可观的回报
Simply Wall St ·  04/26 18:19

This week we saw the PKU HealthCare Corp.,Ltd. (SZSE:000788) share price climb by 14%. But that doesn't change the fact that the returns over the last five years have been less than pleasing. In fact, the share price is down 26%, which falls well short of the return you could get by buying an index fund.

本周我们看到北京大学医疗保健有限公司(深圳证券交易所代码:000788)的股价上涨了14%。但这并不能改变这样一个事实,即过去五年的回报并不令人满意。实际上,股价下跌了26%,远低于购买指数基金所能获得的回报。

On a more encouraging note the company has added CN¥387m to its market cap in just the last 7 days, so let's see if we can determine what's driven the five-year loss for shareholders.

更令人鼓舞的是,该公司的市值在过去的7天内就增加了3.87亿元人民币,因此,让我们看看我们能否确定导致股东五年亏损的原因。

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

用本杰明·格雷厄姆的话来说:从短期来看,市场是一台投票机器,但从长远来看,它是一台称重机。研究市场情绪如何随着时间的推移而变化的一种方法是研究公司股价与其每股收益(EPS)之间的相互作用。

While the share price declined over five years, PKU HealthCareLtd actually managed to increase EPS by an average of 9.4% per year. So it doesn't seem like EPS is a great guide to understanding how the market is valuing the stock. Or possibly, the market was previously very optimistic, so the stock has disappointed, despite improving EPS.

尽管股价在五年内下跌,但PKU HealthcareLtd实际上设法做到了 增加 每股收益平均每年增长9.4%。因此,每股收益似乎不是了解市场如何估值股票的好指南。或者,市场此前可能非常乐观,因此尽管每股收益有所改善,但该股还是令人失望。

Due to the lack of correlation between the EPS growth and the falling share price, it's worth taking a look at other metrics to try to understand the share price movement.

由于每股收益增长与股价下跌之间缺乏相关性,值得一看其他指标,以了解股价走势。

The revenue fall of 2.2% per year for five years is neither good nor terrible. But if the market expected durable top line growth, then that could explain the share price weakness.

五年来收入每年下降2.2%,这既不是好事也不是很糟糕。但是,如果市场预计收入将持续增长,那么这可以解释股价疲软的原因。

The company's revenue and earnings (over time) are depicted in the image below (click to see the exact numbers).

公司的收入和收益(随着时间的推移)如下图所示(点击查看确切数字)。

earnings-and-revenue-growth
SZSE:000788 Earnings and Revenue Growth April 26th 2024
SZSE: 000788 2024年4月26日收益和收入增长

This free interactive report on PKU HealthCareLtd's balance sheet strength is a great place to start, if you want to investigate the stock further.

如果你想进一步调查该股,这份关于PKU HealthcareLtd资产负债表实力的免费互动报告是一个很好的起点。

A Different Perspective

不同的视角

While the broader market lost about 13% in the twelve months, PKU HealthCareLtd shareholders did even worse, losing 23%. Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 5% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. Before deciding if you like the current share price, check how PKU HealthCareLtd scores on these 3 valuation metrics.

尽管整个市场在十二个月中下跌了约13%,但PKU HealthcareLtd股东的表现甚至更糟,下跌了23%。话虽如此,在下跌的市场中,一些股票不可避免地会被超卖。关键是要密切关注基本发展。遗憾的是,去年的业绩结束了糟糕的表现,股东在五年内每年面临5%的总亏损。总的来说,长期股价疲软可能是一个坏兆头,尽管逆势投资者可能希望研究该股以期出现转机。在决定是否喜欢当前股价之前,请查看PKU HealthcareLtd在这三个估值指标上的得分。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

当然,通过寻找其他地方,你可能会找到一笔不错的投资。因此,请看一下我们预计收益将增加的这份免费公司名单。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

请注意,本文引用的市场回报反映了目前在中国交易所交易的股票的市场加权平均回报。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发